Clinical Trial Agreement Sample Clauses

Clinical Trial Agreement. The undersigned,
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Clinical Trial Agreement. After Closing, with respect to the Clinical Trial Agreement, (a) the Purchaser shall cause CroMedica Global Inc. to fulfil all of its obligations in the delivery of the international clinical trial as set out in Exhibit C to the Clinical Trial Agreement (the "International Clinical Trial") at a total remaining cost estimated at $ US 3,000,000 which amount will be considered as a pre-paid expense of the Vendor on Closing; (b) the Purchaser shall cause CroMedica Global Inc. to prepare an interim analysis for the International Clinical Trial at no further cost to the Vendor; (c) the Purchaser shall cause CroMedica Global Inc. to cooperate, using reasonable commercial efforts, with the Vendor to incorporate required modifications into the existing protocol for the International Clinical Trial and to provide associated consultancy services regarding commercialization strategies and product development, with the cost of modifying the existing protocol and the associated regulatory filings to be the responsibility of CroMedica Global Inc.; provided, however, that any additional work (including without limitation an open label extension) or scope changes currently not anticipated and not covered by the terms of the Clinical Trial Agreement resulting from the modification o the protocol shall be invoiced to and paid by the Vendor in accordance with a contract change request to be settled between CroMedica Global Inc. and the Vendor pursuant to the terms of the Clinical Trial Agreement; (d) the Vendor shall negotiate -and execute, and the Purchaser shall cause CroMedica Global Inc. to negotiate and execute, an agreement between the Vendor and CroMedica Global Inc. amending the Clinical Trial Agreement, in a form satisfactory to Purchaser's counsel, acting reasonably, in which the terms of the Clinical Trial Agreement shall be modified to reflect: (i) the work that has been delivered to date, (ii) the additional work relating to the Clinical Trial Agreement to be completed by the Purchaser pursuant to this Agreement, and (iii) the work originally contemplated b the Clinical Trial Agreement which will no longer be undertaken and for which no additional bxxxxxxx will be made (which includes all studies other than the International Clinical Trial and the Bioequivalence Study); provided, however, that the termination fees set forth in the Clinical Trial Agreement shall not apply against the Vendor; (e) the Purchaser shall cause CroMedica Global Inc. to conduct a phase I ...
Sample 1
Clinical Trial Agreement. This Agreement is entered into by and between SMO, a division of XYZ a company registered under the Companies Act. 1956, and_____________________________________________ for the study (Protocol Number: ).
Sample 1
Clinical Trial Agreement. An agreement governing the conduct of a study sponsored by a for-profit entity.
Sample 1
Clinical Trial Agreement. Within [**] following the date on which Research Institute completes the transfer of title and assignment to Licensee of the Product IND pursuant to Section 13.1, the Parties shall negotiate a clinical trial agreement governing the rights and obligations of the Parties with respect to conduct of the Phase I/IIa Trial, which agreement shall have substantially the same intellectual property terms as the Sponsored Research Agreement. DOCPROPERTY DOCXDOCID DMS=InterwovenIManage Format=<<NUM>>_<<VER>> PRESERVELOCATION \* MERGEFORMAT 137212319_3 The Parties have executed this Agreement by their duly authorized officers or representatives, in one or more counterparts, each of which shall be deemed an original but all of which taken together constitute one and the same instrument as of the Effective Date. Research Institute AT NATIONWIDE CHILDREN’S HOSPITAL By: /s/ Xxxxxxx XxXxxxxxxXxxxxxx XxXxxxxxx, Vice President, Commercial and Industry Relations Date 10/8/2018 SAREPTA THERAPEUTICS, INC. By: /s/ Xxxx Xxxxxx Name: Xxxx XxxxxxXxxxx: President & Chief Executive Officer Date 10/8/2018 DOCPROPERTY DOCXDOCID DMS=InterwovenIManage Format=<<NUM>>_<<VER>> PRESERVELOCATION \* MERGEFORMAT 137212319_3 69777295_20 DOCPROPERTY DOCXDOCID DMS=InterwovenIManage Format=<<NUM>>_<<VER>> PRESERVELOCATION \* MERGEFORMAT 137212319_3 69777295_20 DOCPROPERTY DOCXDOCID DMS=InterwovenIManage Format=<<NUM>>_<<VER>> PRESERVELOCATION \* MERGEFORMAT 137212319_3 69777295_20 DOCPROPERTY DOCXDOCID DMS=InterwovenIManage Format=<<NUM>>_<<VER>> PRESERVELOCATION \* MERGEFORMAT 137212319_3 69777295_20 DOCPROPERTY DOCXDOCID DMS=InterwovenIManage Format=<<NUM>>_<<VER>> PRESERVELOCATION \* MERGEFORMAT 137212319_3 69777295_20 DOCPROPERTY DOCXDOCID DMS=InterwovenIManage Format=<<NUM>>_<<VER>> PRESERVELOCATION \* MERGEFORMAT 137212319_3 69777295_20 DOCPROPERTY DOCXDOCID DMS=InterwovenIManage Format=<<NUM>>_<<VER>> PRESERVELOCATION \* MERGEFORMAT 137212319_3
Sample 1
Clinical Trial Agreement. Promptly following the date hereof, the Parties shall negotiate in good faith a clinical trial agreement on customary terms under which Seller and its Affiliates would continue to conduct the TATCIST Study on behalf of Buyer following the Closing (the “Clinical Trial Agreement”).
Sample 1
Clinical Trial Agreement. The undersigned, [insert name of the sponsor], whose registered office is at [insert address], lawfully represented by [insert name(s) and function(s)] (hereinafter referred to as “Sponsor”) and [insert name of institution], whose address is at [insert address], lawfully represented by [insert name(s) and function(s)] (hereinafter referred to as “Institution”) and [INVESTIGATOR], [insert: name of physician …», …[function], [tax/office address and chamber of commerce registration number, if applicable] (hereinafter referred to as “Principal Investigator”)
Sample 1
AutoNDA by SimpleDocs
Clinical Trial Agreement. In the event that Celgene exercises its Celgene Phase 1 Portion Participation Right, at the request of either Party, the Parties shall negotiate in good faith and enter into an appropriate agreement to document the rights granted to Celgene pursuant to this Section 2.2.3.
Sample 1
Clinical Trial Agreement 
Sample 1Sample 2Sample 3See All (4)

Related to Clinical Trial Agreement

  • Collaboration Agreement The Collaboration Agreement shall not have been terminated in accordance with its terms and shall be in full force and effect.

  • Clinical 1.1 Provides comprehensive evidence based nursing care and individual case management to a specific group of patients/clients including assessment, intervention and evaluation. 1.2 Undertakes clinical shifts at the direction of senior staff and the Nursing Director including participation on the on-call/after-hours/weekend roster if required. 1.3 Responsible and accountable for patient safety and quality of care through planning, coordinating, performing, facilitating, and evaluating the delivery of patient care relating to a particular group of patients, clients or staff in the practice setting. 1.4 Monitors, reviews and reports upon the standard of nursing practice to ensure that colleagues are working within the scope of nursing practice, following appropriate clinical pathways, policies, procedures and adopting a risk management approach in patient care delivery. 1.5 Participates in xxxx rounds/case conferences as appropriate. 1.6 Educates patients/carers in post discharge management and organises discharge summaries/referrals to other services, as appropriate. 1.7 Supports and liaises with patients, carers, colleagues, medical, nursing, allied health, support staff, external agencies and the private sector to provide coordinated multidisciplinary care. 1.8 Completes clinical documentation and undertakes other administrative/management tasks as required. 1.9 Participates in departmental and other meetings as required to meet organisational and service objectives. 1.10 Develops and seeks to implement change utilising expert clinical knowledge through research and evidence based best practice. 1.11 Monitors and maintains availability of consumable stock. 1.12 Complies with and demonstrates a positive commitment to Regulations, Acts and Policies relevant to nursing including the Code of Ethics for Nurses in Australia, the Code of Conduct for Nurses in Australia, the National Competency Standards for the Registered Nurse and the Poisons Act 2014 and Medicines and Poisons Regulations 2016. 1.13 Promotes and participates in team building and decision making. 1.14 Responsible for the clinical supervision of nurses at Level 1 and/or Enrolled Nurses/ Assistants in Nursing under their supervision.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • Development Agreement As soon as reasonably practicable following the ISO’s selection of a transmission Short-Term Reliability Process Solution, the ISO shall tender to the Developer that proposed the selected transmission Short-Term Reliability Process Solution a draft Development Agreement, with draft appendices completed by the ISO to the extent practicable, for review and completion by the Developer. The draft Development Agreement shall be in the form of the ISO’s Commission-approved Development Agreement for its Reliability Planning Process, which is in Appendix C in Section 31.7 of Attachment Y of the ISO OATT, as amended by the ISO to reflect the Short-Term Reliability Process. The ISO and the Developer shall finalize the Development Agreement and appendices as soon as reasonably practicable after the ISO’s tendering of the draft Development Agreement. For purposes of finalizing the Development Agreement, the ISO and Developer shall develop the description and dates for the milestones necessary to develop and construct the selected project by the required in-service date identified in the STAR or Generator Deactivation Assessment, including the milestones for obtaining all necessary authorizations. Any milestone that requires action by a Connecting Transmission Owner or Affected System Operator identified pursuant to Attachment P of the ISO OATT to complete must be included as an Advisory Milestone, as that term is defined in the Development Agreement. If the ISO or the Developer determines that negotiations are at an impasse, the ISO may file the Development Agreement in unexecuted form with the Commission on its own, or following the Developer’s request in writing that the agreement be filed unexecuted. If the Development Agreement is executed by both parties, the ISO shall file the agreement with the Commission for its acceptance within ten (10) Business Days after the execution of the Development Agreement by both parties. If the Developer requests that the Development Agreement be filed unexecuted, the ISO shall file the agreement at the Commission within ten (10) Business Days of receipt of the request from the Developer. The ISO will draft, to the extent practicable, the portions of the Development Agreement and appendices that are in dispute and will provide an explanation to the Commission of any matters as to which the parties disagree. The Developer will provide in a separate filing any comments that it has on the unexecuted agreement, including any alternative positions it may have with respect to the disputed provisions. Upon the ISO’s and the Developer’s execution of the Development Agreement or the ISO’s filing of an unexecuted Development Agreement with the Commission, the ISO and the Developer shall perform their respective obligations in accordance with the terms of the Development Agreement that are not in dispute, subject to modification by the Commission. The Connecting Transmission Owner(s) and Affected System Operator(s) that are identified in Attachment P of the ISO OATT in connection with the selected transmission Short-Term Reliability Process Solution shall act in good faith in timely performing their obligations that are required for the Developer to satisfy its obligations under the Development Agreement.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!